Phase 2a Liver + friends diseases Flashcards
What are some functions of the liver and what are associated diseases should there be a problem with those functions?
- Oestrogen level regulation - Gynecomastia, palmar erythema, spider naevi
Albumin - Ascites + oedema
Clotting factors - bleeding disorders
Storage (vitamins, iron, copper fat) – Wilson’s haemachromatosis, A1AT deficiency
Immune system response - Kuppfer cells –> Spontaneous bacterial peritonitis
Detoxification - Hepatic encephalopathy
Bilirubin metabolism - Jaundice
What is the normal AST:ALT
(Aspartate transaminase:Alanine transaminase)
What does a ratio of:
>2:1
>4.5:1
<0.9:1
Suggest
1:1 - normal
> 2:1 - Alcoholic liver disease (esp with increased GGT)
> 4.5:1 - Wilson’s/hyperthyroidism
<0.9:1 - NAFLD
Where is ALT and AST usually found?
Liver, heart, kidney and muscles
What does increased ALP (Alkaline phosphatase) suggest?
Increased biliary tree specific damage
Acute liver failure
RF
Path
Symptoms
Investigations
Treatments
Rare, life threatening condition with a rapid decline in hepatic function. Characterised by Jaundice, coagulopathy (INR >1.5) and hepatic encephalopathy in patients with NO EVIDENCE of prior liver disease.
(if it occurs in patients with previous liver disease –> acute on chronic liver failure
RF - Chronic alcohol misuse, females, >40 years, fasting
PATHOLOGY
Acute liver failure - results in massive hepatocyte necrosis and can result in organ failure
Most common cause - PARACETAMOL OVERDOSE
Other causes: Autoimmune hepatitis, Hepatitis E, A and B, Budd chiari syndrome (obstruction of hepatic venous outflow)
SYMPTOMS
- Jaundice
- Coagulopathy
- Malaise, n+v
- Signs of hepatic encephalopathy
(West Haven criteria. Grade 1 - subtly impaired awareness, 2 - personality change, lethargy 3- somnolent, marked confusion 4 - coma
INVESTIGATIONS
First - Liver function test
- Increased bilirubin, increased PT/INR and decreased serum albumin
- Increased ALT and AST
Additional but not really required?
- FBC - (for haemolytic anaemia associated with Wilson’s disease)
- Abdominal ultrasound - to eliminate budd chiari syndrome
- EEG - electroencephalogram - assess hepatic encephalopathy
MANGEMENT
1st - Intensive care management
- Tracheal intubation
- Analgesia
- IV fluids
Then treat underlying cause
- Paracetamol causes - N acetylcysteine
- Budd chiari syndrome - LMWH
Treat complications
- Cerebral oedema - IV mannitol
- HE - Lactulose
- Ascites - Spironolactone
- Haemorrhage - vitamin K
Definitive - Liver transplant
Symptoms of sepsis and treatment for sepsis
Sepsis - chills, confusion, fever, tachycardia, hypotension
Treatment with sepsis 6
Give 3 - Oxygen, antibiotics, fluids
Take 3 - cultures, lactate measurement and urine output
Alcoholic Liver disease
RF
Path
Symptoms
Investigations
Treatments
Liver disease caused by chronic heavy alcohol ingestion
RF - heavy Alcohol consumption, female sex, smoking, hep C
PATHOLOGY
- Metabolism of alcohol produces FAT in the liver (through alcohol dehydrogenase and NADH)
- Reactive oxygen species are also produced which can damage hepatocytes (cause necrosis and apoptosis)
3 stages
Fatty liver undamaged (steatosis - initial fatty deposits) –> Alcoholic hepatitis (inflammation and necrosis) - mallory bodies –> Alcoholic liver cirrhosis (micronodular and irreversible)
SYMPTOMS
Early - RUQ discomfort, hepatomegaly
Later - more severe - Jaundice, ascites, palmar erythema, dupuytren’s contracture, asterixis
INVESTIGATIONS
First - LIVER FUNCTION TEST
- Increased bilirubin, decreased albumin, increased PT
- AST:ALT >2
FBC - Macrocytic anaemia (increased deposition of cholesterol on RBC membrane)
GS - Liver biopsy - shows extent of alcoholic liver disease
(Can do AUDIT and CAGE questionnaire)
TREATMENT
1st - STOP DRINKING ALCOHOL + give diazepam for alcohol withdrawal symptoms (delirium tremens)
- Consider prednisolone based on Maddrey’s discriminant function (>32 positive, poor prognosis)
Tranexamic acid (to reduce/prevent bleeding)- reduces mortality risk in GI bleeds
Definitive - Liver transplant
Complications - HE, Acites, hepatocellular carcinoma, Wernicke krsakoff syndrome
2 questionnaires you use for alcoholic liver disease
First line - AUDIT questionnaire (10 MCQs)
CAGE questionnaire
- Do you ever think you should Cut down
- Do you get Annoyed at others commenting on your drinking?
- Do you ever feel Guilty about drinking?
- Do you drink in the morning (Eye opening)
2 or more considered dependent
What does a patient need to do to be eligible for consideration for liver transplant?
Abstain from alcohol for at least 3 months.
What is wernicke korsakoff syndrome?
Alcohol excess leads to thiamine (B1) deficiency as thiamine is poorly absorbed in the presence of alcohol.
Symptoms: Memory impairment and behavioural changes, ataxia, nystagmus, confusion
Medical emergency which can be treated with IV thiamine. (and abstain from alcohol)
Non Alcoholic Fatty Liver Disease
RF
Path
Symptoms
Investigations
Treatments
Evidence of hepatic steatosis in the absence of significant alcohol consumption
NAFLD - Hepatic steatosis without evidence of hepatocellular injury
–>
NASH (non alcoholic steatohepatitis) - hepatic steatosis and inflammation with hepatocyte injury
–>
Fibrosis
–> Cirrhosis
(Associated with hypertension, obesity and diabetes)
Symptoms
Typically asymptomatic initially
- Obese patients may present with : fatigue, malaise, RUQ discomfort, hepatosplenomegaly
INVESTIGATIONS
Liver function test - Increased ALT (but ALT:AST <0.9)
GS - Liver biopsy
Liver ultrasound - use fibrosis 4 score to estimate risk of advanced fibrosis and need for liver biopsy
TREATMENT
First - Lifestyle modification- Healthy diet and exercise for weight loss (no smoking and alcohol)
Vitamin E to improve histological fibrotic liver appearance.
(Can lead to HCC, HE, Ascites, portal hypertension)
Liver Cirrhosis
RF
Path
Symptoms
Investigations
Treatments
The result of chronic inflammation and damage to liver cells. –> characterised by fibrosis and replacement of functional liver cells with scar tissue - nodules of scar tissue form within the liver
RF - Alcohol misuse, IVDU, obesity
PATHOLOGY
Most common causes
- Alcohol related liver disease
- NAFLD
- Chronic viral hepatitis (B and C)
Hepatic fibrosis activates hepatic stellate cells –> they contract and increase portal resistance –> leading to portal hypertension. (leads to complications)
Compensated cirrhosis - early stage where liver can still perform functions despite fibrosis
Decompensated cirrhosis - Advanced stage where liver can’t compensate for extensive damage which leads to development of complications. (jaundice, ascites, HE)
SYMPTOMS
Abdominal features - hepatomegaly, splenomegaly, abdominal distension
Hand and nail features - leukonychia, palmar erythema, spider naevi, finger clubbing, dupuytren’s contracture
INVESTIGATIONS
LFT - low albumin, raised bilirubin, raised prothrombin time
- Platelet count reduced (liver has impaired ability to produce thrombopoietin)
Abdominal ultrasound - liver surface nodularity, ascites, splenomegaly
(Transient elastography for determining degree of fibrosis)
GS - Liver biopsy
(Use child pugh score for prognosis of patients with chronic liver failure/cirrhosis - severity of liver cirrhosis)
TREATMENT
3 things
1) Treat underling cause
- avoid alcohol, NSAIDS, high dose paracetamol, treat any hep B and C
2) Monitor complications
e.g. use ultrasound to monitor ascites and endoscopy to monitor oesophageal varices
3) Manage complications e.g. spironolactone/diuretics for ascites
2nd line - Liver transplant
Chronic liver failure
Causes
Symptoms
Investigations
Treatment
What is it a huge risk factor of developing
Main cause: Alcoholic liver disease
Other causes:
- NAFLD
- Hepatitis B a. nd C
- Budd chiari
- Autoimmune
Symptoms
- Ascites, asterixis
- Clubbing, Coagulopathy
- Dupuytren’s contracture
- Palmar Erythema
- Gynaecomastia
- Hepatomegaly, HE, portal Hypertension
- Increase in size of parotid gland
- Jaundice
- Spider naevi
INVESTIGATIONS
- LFT (increased AST, ALT), ascitic tap culture (eliminates SBP/Identifies bacteria causing SBP)
- GS - Liver biopsy
Assessing hepatic function –> Prothrombin time
Treatment
- Lifestyle modification prevents progression (decrease alcohol, decrease BMI)
Definite - liver transplant
Manage complication
HE - Lactulose
Ascites - diuretics
SBP
HUGE RISK OF DEVELOPING HEPATIC CELLULAR CARCINOMA
Hepatitis A
RF
Path
Symptoms
Investigations
Treatments
- An RNA virus with a faecal-oral mode of transmission (not associated with Chronic liver disease like B and C)
PATHOLOGY
- Faeco-oral route of transmission (can be via foods - SHELLFISH)
- After oral inoculation –> virus enters hepatocytes and replicates –> virus particles secreted into bile and blood –> virus is either excreted in stool or reabsorbed via enterohepatic circulation –> (Liver injury occurs when cytotoxic T cells lyse the infected hepatocytes)
SYMPTOMS
Takes 1-2 weeks after infection.
Initial : (pre-jaundice) - fever, N+V, malaise
Afterwards: Jaundice, dark urine + pale stools (obstruction of bile duct due to liver inflammation), hepatosplenomegaly
Investigations
First - LFT - increased bilirubin, increased transaminase (high ALT than AST)
Hepatitis A viral serology –> Positive for IgM antibodies for hep A
TREATMENT
Supportive treatment (pain/itch relief)
(6 weeks self limiting)
For high risk/prevention –> Vaccine is available
Hepatitis B
RF
Path
Symptoms
Investigations
Treatments
Double stranded DNA virus - transmitted by blood or bodily fluids
(Sex, vertical transmission, needles)
RF: IVDU, born in endemic region, healthcare workers
PATHOLOGY
SYMPTOMS
- Mostly asymptomatic till jaundice onset
–> Jaundice, hepatosplenomegaly, (possible hepatocellular carcinoma/cirrhosis + complications)
INVESTIGATION
FIRST - Serology
- Screening involves testing for HbcAb (core antibody) and HbsAg (surface antigen)
- Measuring IgM and IgG of HbcAb:
+ IgM - active infection (higher in acute, lower in chronic)
+ IgG - Past infection (where HbsAg is negative)
- If HbeAG is present –> patient is in an acute phase of infection where virus is actively replicating
MANAGEMENT
First (chronic) - Pegylated interferon alfa 2a
In severe symptoms - Antiviral therapy with entecavir
Acute –> supportive treatment e.g. fluids, healthy diet. (can achieve seroconversion without treatment)
Can use vaccine for PREVENTION
What do these help to indicate?
Surface antigen (HbsAg)
E antigen (HbeAg)
Core antibodies (HbcAb)
Surface antibodies (HbsAb)
Hepatitis B virus DNA
Surface antigen - is an indication of active infection
E antigen - is a marker of viral replication and implies high infectivity
Core antibodies.- implies past or current infection
Surface antibodies - implies vaccination/past infection/
(possibly current infection also)
Hepatitis B virus DNA - a direct count of viral load
Hepatitis C
RF
Path
Symptoms
Investigations
Treatments
An RNA virus causing inflammation of the liver
RF - Alcohol, White populated countries
PATHOLOGY
ALCOHOL CULTURE CAUSES IT)
Transmitted by: percutaneous blood exposure and bodily fluids: IVDU, sex
(Unsafe injection practices during medical treatment, IVDU, blood transfusion)
SYMPTOMS
Acute - often asymptomatic
Chronic - possible chronic liver disease symptoms - HEPATOSPLENOMEGALY, (ascites, jaundice, HE)
INVESTIGATIONS
1st - Screen for hepatitis C antibody and hepatitis C RNA virus
(some people would have cleared the virus without treatment - positive C antibody, negative C RNA virus)
MANAGEMENT
Direct Acting Antivirals
- Sofosbuvir + Ribavarin
Hepatitis D
RF
Path
Symptoms
Investigations
Treatments
Defective RNA virus that requires hepatitis B virus surface antigen in order to propagate
RF- HBV infection, IVDU, sex
PATHOLOGY
Can infect susceptible hosts (with HBV) via:
1) Simultaneous co infection with HBV
2) Superinfection of an individual with chronic HBV infection
3) Blood, bodily fluids, sexual routes
(It increases the complications and disease severity of HBV)
SYMPTOMS
Initially- asymptomatic
(After incubation of 3-7 weeks –> Jaundice, ascites)
INVESTIGATION
Serology for:
- HBV surface antigen, surface antibody, core antibody, e antigen, e antibody,
- Serum HBV DNA
- Serum HDV RNA
MANAGEMENT
Supportive treatment + pegylated interferon alfa 2a
Hepatitis E
Path
Symptoms
Investigations
Treatments
RNA virus transmitted by faecal oral route
PATHOLOGY
Spread via faecal oral route:
- Contaminated drinking water
- Consumption of UNCOOKED PORK/deer meat
RF - PREGNANT LADIES
Mostly self limiting
(May progress to chronic hepatitis and liver failure - in immunocompromised patients) - with mortality in pregnant ladies being 10-20%
SYMPTOMS
Initially - fever, nausea and vomiting
Later stage - abdominal pain, jaundice and hepatomegaly
INVESTIGATION
Serology
HEV IgM - acute infection
HEV RNA - viral load
TREATMENT
Supportive treatment - self limiting virus
Autoimmune hepatitis
RF
Path
Symptoms
Investigations
Treatments
Chronic inflammatory disease of the liver. Characterised by the presence of circulating auto-antibodies with high serum globulin
RF - Females, other autoimmune diseases (SLE), genetic predisposition (HLA DR3/DR4), measles
PATHOLOGY
Type 1 - affects women in late 40s to 50s (less acute)
- Anti nuclear antibodies (ANA)
- Anti smooth muscle antibodies
- Anti soluble liver antigen (anti-SLA)
Type 2 - affects children or younger people (Acute hepatitis)
- Anti liver kidney microsomes (anti-LKM1)
- Anti liver cytosol antigen (Anti-LC1)
Symptoms
Some are asymptomatic, some present with
- ABD discomfort
- Hepatomegaly
- Jaundice
INVESTIGATIONS
Serology for:
- Anti nuclear antibodies (ANA)
- Anti smooth muscle antibodies (ASMA)
- (Anti soluble liver antigen (anti-SLA)
and)
- Anti liver kidney microsomal type 1 (anti-LKM1)
- Anti liver cytosol antigen (Anti-LC1)
MANAGEMENTS
High dose corticosteroid + immunosuppressant
Prednisolone + Azathioprine
Last resort liver transplant
Symptoms and treatment of Crigler Najjar syndrome
Extremely rare
Symptoms - Severe jaundice with N+V
Persistent yellowing of eyes and skin which become apparent SHORTLY AFTER BIRTH
TREATMENT - Phototherapy (which helps breakdown unconjugated bilirubin)
(can result in kernicterus if untreated - bilirubin induced neurological damage - mostly in infants)
Gilbert syndrome
RF
Path
Symptoms
Investigations
Treatments
An autosomal recessive disorder where there is decreased levels of the enzyme UDP glucuronosyltransferase resulting in impaired conjugation of bilirubin. (Non haemolytic unconjugated hyperbilirubinaemia)
RF - post pubertal age, family history of Gilbert syndrome, T1DM
PATHOLOGY
- UDP glucuronosyltransferase is an enzyme responsible for the rate limiting step of bilirubin conjugation
- Because of an autosomal recessive mutation in the UGT1A1 gene - enzymatic function becomes defective resulting in unconjugated hyperbilirubinemia
SYMPTOMS
- Painless jaundice
- Crigler Najjar syndrome - more severe jaundive with N+V (persistent yellowing of the skin and whites of eyes which become apparent shortly after birth)
INVESTIGATION
- Unconjugated bilirubin - elevated
(UGT1A1 genotyping - presence of mutation)
TREATMENT
No need treatment, just patient education (they may become jaundiced in certain situations of increased stress: fasting, sleep deprivation, heavy physical exertion)
For Crigler Najjar syndrome (another flash card ) - but phototherapy
Causes of prehepatic jaundice - 2
Jaundice - result of accumulation of bilirubin in the bloodstream and subsequent deposition in the skin, sclera and mucous membranes.
Pre hepatic causes
- An increase in unconjugated bilirubin due to increased bilirubin production –> HAEMOLYTIC ANAEMIAS (sickle cell, autoimmune, thalassemia, G6PD deficiency, malaria)
- Portal vein stenosis
- Gilbert’s syndrome - mutation to UGT1A1 gene - decreased conjugation of bilirubin